STAPHYLOCOCCUS AUREUS NASAL CARRIAGE AMONG INJECTING AND NON-INJECTING DRUG USERS AND ANTIMICROBIAL SUSCEPTIBILITY

被引:0
|
作者
Varshochi, Mojtaba [1 ,2 ]
Attari, Zahra [2 ]
Hasani, Alka [3 ]
Seidi, Ali [4 ]
机构
[1] Tabriz Univ Med Sci, Fac Med, Res Ctr Infect Dis & Trop Med, Dept Infect Dis, Tabriz, Iran
[2] Tabriz Univ Med Sci, Fac Med, Dept Infect Dis, Tabriz, Iran
[3] Tabriz Univ Med Sci, Fac Med, Dept Microbiol, Tabriz, Iran
[4] Tabriz Univ Med Sci, Fac Med, Dept Psychiat, Tabriz, Iran
关键词
Staphylococcus Aureus; Drug Addicts; Nasal Carriers; Antimicrobial Susceptibility;
D O I
10.3844/ajidsp.2013.34.39
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Staphylococcus Aureus (SA) is one of the most prevalent bacterial pathogens in human beings. Approximately 20% of healthy persons are persistent carriers and 60% are intermittent carriers of SA. Nasal cavity is one of the most important sites of its colonization. Intravenous (IV) drug abuse has been proposed as a risk factor for colonization of SA in the nasal mucosa. The goal of this study was to determine the frequency of SA carriers in nasal cavity among IV and non-IV drug abusers (addicts), as well as to assess the antimicrobial susceptibility pattern of the positive cases. In a cross-sectional analysis of 300 drug addicts (Group I: 100 non-injecting addicts, Group II: 100 IV injecting drug addicts in rehab, Group III: 100 IV injecting drug addicts not in rehab) in the infectious diseases clinics of Tabriz's Imam Reza and Sina teaching hospitals and the rehabilitation center of Razi hospital, were investigated. Hospitalized addicts, insulin-dependent diabetic cases, HIV positive patients and those on chronic hemodialysis were excluded. The nasal mucosal sample was prepared from each case for SA isolation and its antimicrobial susceptibility was investigated by antibiogram. Eighty-four cases (28%) were culture positive for SA, including 26 cases in group one, 32 cases in group two and 26 cases in group three (p = 0.55). There was only one MRSA isolate present in all the cases studied (1.2%). No resistance to linozolid, rifampin and vancomycin was observed. The resistance to erythromycin, cefoxitin, ciprofloxacin, clindamycin, co-trimoxazol and gentamicin were 3.6, 4.8, 2.4, 3.6, 1.2 and 2.4% respectively. No statistically significant differences existed between the three groups in antibacterial susceptibility pattern. Sensitivity to oxacillin using the E-test results and disc diffusion were completely consistent. The percentage of carries of SA in the anterior nasal mucosa among IV and non-IV drug addicts is not considerably higher than the general population. MRSA isolates were uncommon in our cases. However, given the importance of localized and systemic infections in this group, early detection and treatment is reasonable.
引用
收藏
页码:34 / 39
页数:6
相关论文
共 50 条
  • [1] Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City
    Des Jarlais, Don C.
    Arasteh, Kamyar
    Perlis, Theresa
    Hagan, Holly
    Abdul-Quader, Abu
    Heckathorn, Douglas D.
    McKnight, Courtney
    Bramson, Heidi
    Nemeth, Chris
    Torian, Lucia V.
    Friedman, Samuel R.
    AIDS, 2007, 21 (02) : 231 - 235
  • [2] Epidemiology of HIV among injecting and non-injecting drug users: Current trends and implications for interventions
    Strathdee S.A.
    Stockman J.K.
    Current HIV/AIDS Reports, 2010, 7 (2) : 99 - 106
  • [3] Predictors of mortality among injecting and non-injecting HIV-negative drug users in northern Thailand
    Quan, Vu Minh
    Vongchak, Tasanai
    Jittiwutikarn, Jaroon
    Kawichai, Surinda
    Srirak, Namtip
    Wiboonnatakul, Kanokporn
    Razak, Myat Htoo
    Suriyanon, Vinai
    Celentano, David D.
    ADDICTION, 2007, 102 (03) : 441 - 446
  • [4] Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users
    Roy, KM
    Goldberg, DJ
    Hutchinson, S
    Cameron, SO
    Wilson, K
    MacDonald, L
    JOURNAL OF MEDICAL VIROLOGY, 2004, 74 (01) : 62 - 66
  • [5] Chronic hepatitis C in injecting drug users: a comparison with non-injecting drug users in the same geographic area
    Price, D. A.
    Schmid, M. L.
    Agarwal, K.
    Hewett, M.
    Craig, W. L.
    Burt, A. D.
    Bassendine, M. F.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S212 - S212
  • [6] Injecting transition risk and depression among Mexican American non-injecting heroin users
    Cepeda, Alice
    Kaplan, Charles
    Neaigus, Alan
    Cano, Miguel Angel
    Villarreal, Yolanda
    Valdez, Avelardo
    DRUG AND ALCOHOL DEPENDENCE, 2012, 125 : S12 - S17
  • [7] Heroin sniffing as self-regulation among injecting and non-injecting heroin users
    Sotheran, JL
    Goldsmith, DS
    Blasco, M
    Friedman, SR
    JOURNAL OF DRUG ISSUES, 1999, 29 (02) : 401 - 421
  • [8] Inconsistent use of condoms in non-injecting illicit drug users
    Guimaraes, Rafael Alves
    Rodovalho, Aurelio Goulart
    Fernandes, Inaina Lara
    Lucchese, Roselma
    Vera, Ivania
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2016, 20 (02): : 220 - 221
  • [9] HIV-1 subtypes in injecting drug users & their non-injecting wives in Manipur, India
    Chakrabarti, S
    Panda, S
    Chatterjee, A
    Sarkar, S
    Manna, B
    Singh, NB
    Naik, TN
    Detels, R
    Bhattacharya, SK
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2000, 111 : 189 - 194
  • [10] Risk of HCV Infection in Injecting and Non-Injecting Drug Users Receiving Opioid Substitution Therapy
    Wang, Chih-Wen
    Yu, Ming-Lung
    Dai, Chia-Yen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 165 - 165